These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12424197)

  • 1. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease.
    Locatelli F; Rocha V; Reed W; Bernaudin F; Ertem M; Grafakos S; Brichard B; Li X; Nagler A; Giorgiani G; Haut PR; Brochstein JA; Nugent DJ; Blatt J; Woodard P; Kurtzberg J; Rubin CM; Miniero R; Lutz P; Raja T; Roberts I; Will AM; Yaniv I; Vermylen C; Tannoia N; Garnier F; Ionescu I; Walters MC; Lubin BH; Gluckman E;
    Blood; 2003 Mar; 101(6):2137-43. PubMed ID: 12424197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial.
    Locatelli F; Bruno B; Zecca M; Van-Lint MT; McCann S; Arcese W; Dallorso S; Di Bartolomeo P; Fagioli F; Locasciulli A; Lawler M; Bacigalupo A
    Blood; 2000 Sep; 96(5):1690-7. PubMed ID: 10961865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
    Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R
    Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft-versus-host disease (GVHD) prophylaxis by using methotrexate decreases pre-engraftment syndrome and severe acute GVHD, and accelerates engraftment after cord blood transplantation.
    Iguchi A; Terashita Y; Sugiyama M; Ohshima J; Sato TZ; Cho Y; Kobayashi R; Ariga T
    Pediatr Transplant; 2016 Feb; 20(1):114-9. PubMed ID: 26526424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.
    Ross M; Schmidt GM; Niland JC; Amylon MD; Dagis AC; Long GD; Nademanee AP; Negrin RS; O'Donnell MR; Parker PM; Smith EP; Snyder DS; Stein AS; Wong RM; Forman SJ; Blume KG; Chao NJ
    Biol Blood Marrow Transplant; 1999; 5(5):285-91. PubMed ID: 10534058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
    Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
    Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants.
    Gaziev D; Galimberti M; Lucarelli G; Polchi P; Giardini C; Angelucci E; Baronciani D; Sodani P; Erer B; Biagi MD; Andreani M; Agostinelli F; Donati M; Nesci S; Talevi N
    Bone Marrow Transplant; 2000 Apr; 25(8):815-21. PubMed ID: 10808201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Umbilical cord blood transplantation for children with thalassemia and sickle cell disease.
    Ruggeri A; Eapen M; Scaravadou A; Cairo MS; Bhatia M; Kurtzberg J; Wingard JR; Fasth A; Lo Nigro L; Ayas M; Purtill D; Boudjedir K; Chaves W; Walters MC; Wagner J; Gluckman E; Rocha V; ; ;
    Biol Blood Marrow Transplant; 2011 Sep; 17(9):1375-82. PubMed ID: 21277376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].
    Wang J; Song X; Zhang W; Tong S; Hou J; Chen L; Lou J; Li H; Ding X; Min B
    Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):507-10. PubMed ID: 12133492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation.
    Iravani M; Mousavi A; Gholibeikian S; Bahar B; Samiee S; Ashouri A; Eghbal L; Ghavamzadeh A
    Bone Marrow Transplant; 2005 Jun; 35(11):1095-9. PubMed ID: 15821773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin.
    Soni S; Gross TG; Rangarajan H; Baker KS; Sturm M; Rhodes M
    Pediatr Blood Cancer; 2014 Sep; 61(9):1685-9. PubMed ID: 24740582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling.
    Locatelli F; Kabbara N; Ruggeri A; Ghavamzadeh A; Roberts I; Li CK; Bernaudin F; Vermylen C; Dalle JH; Stein J; Wynn R; Cordonnier C; Pinto F; Angelucci E; Socié G; Gluckman E; Walters MC; Rocha V;
    Blood; 2013 Aug; 122(6):1072-8. PubMed ID: 23692854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Goal-Oriented Monitoring of Cyclosporine Is Effective for Graft-versus-Host Disease Prevention after Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia Major.
    Gauthier A; Bleyzac N; Garnier N; Kebaili K; Joly P; Goutagny MP; Mollet I; Goutelle S; Renard C; Bertrand Y
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2285-2291. PubMed ID: 32007639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.
    Horan JT; Liesveld JL; Fenton P; Blumberg N; Walters MC
    Bone Marrow Transplant; 2005 Jan; 35(2):171-7. PubMed ID: 15531901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies.
    Gaziev J; Marziali S; Paciaroni K; Isgrò A; Di Giuliano F; Rossi G; Marziali M; De Angelis G; Alfieri C; Ribersani M; Andreani M; Palmieri MG; Placidi F; Romigi A; Izzi F; Floris R; Mercuri NB
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1531-1540. PubMed ID: 28602890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of unrelated umbilical cord blood stem cell transplantation for 65 patients in China].
    Liao C; Yang X; Xu ZP; Huang YN; Wu SQ; Chen JS; Li Y; Tang XW; Wu JY
    Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):220-3. PubMed ID: 16624064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced-Intensity Conditioning: Results of a Phase I Trial.
    Abraham A; Cluster A; Jacobsohn D; Delgado D; Hulbert ML; Kukadiya D; Murray L; Shenoy S
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1587-1592. PubMed ID: 28578010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Aschan J; Ringdén O
    Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with hemoglobinopathies.
    Soni S; Boulad F; Cowan MJ; Scaradavou A; Dahake J; Edwards S; Walters MC
    Pediatr Blood Cancer; 2014 Sep; 61(9):1690-4. PubMed ID: 24803091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).
    Kamani NR; Walters MC; Carter S; Aquino V; Brochstein JA; Chaudhury S; Eapen M; Freed BM; Grimley M; Levine JE; Logan B; Moore T; Panepinto J; Parikh S; Pulsipher MA; Sande J; Schultz KR; Spellman S; Shenoy S
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1265-72. PubMed ID: 22343376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.